AIM: To compare characteristics and outcomes of resected and nonresected main-duct and
mixed intraductal papillary mucinous neoplasms of the pancreas (IPMN). METHODS: Over a …

Methods: The clinical data of 96 IPMN cases treated in our hospital between January 2006
and December 2013 were retrospectively analyzed. Among the 96 patients (58 male and 38 …

Background: intraductal papillary mucinous neoplasm (IPMN) shows a series of lesions
which evolve from benign lesions–adenoma–to invasive carcinoma. Aim: to analyze the …

Abstract Background and Aim The evidence for main pancreatic duct intraductal papillary
mucinous neoplasms (MPD‐IPMN) malignancy is based predominantly on investigation of …

Abstract Background/Purpose Appropriate surgical treatment strategies based on
clinicopathological findings are unavailable for intraductal papillary mucinous neoplasm …

Objective: To describe clinical characteristics and outcomes of a large cohort of intraductal
papillary mucinous neoplasms (IPMNs) of the pancreas affecting the main pancreatic duct …

Background Resection is recommended for main duct intraductal papillary mucinous
neoplasms (IPMNs) of the pancreas because of the high risk of malignancy, but the …

Intraductal papillary mucinous neoplasms (IPMNs), characterized by intraductal papillary
growth and thick mucin secretion, have increasingly been recognized. Despite modern …

By comparing the clinicopathological features and survivals between the resected and non-
resected intraductal papillary mucinous neoplasms (IPMNs) of the pancreas, this study tried …

Background/Aims: Although surgical resection is recommended for all main duct-type
intraductal papillary mucinous neoplasms (IPMNs), controversies remain over the precise …